To Name :
To Email :
From Name :
From Email :
Comments :

Commentary


ICD shocks and anxiety: Chicken or egg?

Vol. 6, No. 11 / November 2007
This week's quiz:
More »

In “Managing anxiety in patients with implanted cardiac defibrillators” (Current Psychiatry, September 2007), Drs. Douglas P. Gibson and Kristin K. Kuntz address the potential psychiatric sequela of shocks from implanted cardiac defibrillators (ICDs). Depression is a known risk factor for developing and dying from cardiac disease,1 and recent evidence suggests that anxiety disorders also are associated with increased cardiac risk.2 Autonomic dysfunction is 1 potential mechanism that could explain the increased cardiac mortality associated with depression and anxiety. Patients with depression have a higher risk of ICD shocks induced by ventricular arrhythmias than nondepressed patients.3 This suggests a vicious circle when anxiety and depression could increase arrhythmic risk through autonomic dysfunction, and arrhythmias leading to ICD shocks may cause or worsen depression and anxiety.

Drs. Gibson and Kuntz also describe how cognitive-behavioral therapy (CBT) can reduce anxiety and depressive symptoms associated with ICD shocks. A paper published last year described how CBT may help decrease ICD shocks.4 Therefore it is possible that psychotherapeutic interventions such as CBT may do more than help improve depression and anxiety symptoms, whether preceded or caused by ICD shocks. CBT also might help reduce ventricular arrhythmias. This is important because we do not have good empiric evidence that current treatments for depression—pharmacologic or psychotherapeutic—reduce cardiac risk.1

A recent paper suggests that autonomic dysfunction may improve with sertraline treatment.5 However, the rationale for treating cardiac patients for depression and anxiety should be improvement of psychiatric symptoms and not an as-yet-unfounded belief that such treatments may also reduce the cardiac mortality and morbidity.

Jonas Hannestad, MD, PhD
Department of psychiatry
Yale University
New Haven, CT

References

1. Rivelli S, Jiang W. Depression and ischemic heart disease: what have we learned from clinical trials? Curr Opin Cardiol 2007;22(4):286-91.

2. Bedi US, Arora R. Cardiovascular manifestations of posttraumatic stress disorder. J Natl Med Assoc 2007;99(6):642-9.

3. Whang W, Albert CM, Sears SF, Jr, et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005;45(7):1090-5.

4. Chevalier P, Cottraux J, Mollard E, et al. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J 2006;151(1):191.-

5. Glassman AH, Bigger JT, Gaffney M, Van Zyl LT. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertra-line and mood improvement. Arch Gen Psychiatry 2007;64(9):1025-31.

To comment on articles in this issue or other topics, send letters in care of Erica Vonderheid, Current Psychiatry, 110 Summit Avenue, Montvale, NJ 07645, erica.vonderheid@dowdenhealth.com or visit CurrentPsychiatry.com and click on the “Contact Us” link.

Did you miss this content?
Prescriber’s guide to using 3 new antidepressants: Vilazodone, levomilnacipran, vortioxetine